We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Clinical Data Announces Renewed DNA Sequencing Contract with MRC

Want a FREE PDF version of this news story?

Complete the form below and we will email you a PDF version of "Clinical Data Announces Renewed DNA Sequencing Contract with MRC "

Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.
Read time:

Clinical Data, Inc. has announced that it has been re-selected as an official supplier to the Medical Research Council (MRC) for DNA sequencing along with two other DNA sequencing companies.

The Company's Cogenics division (formerly Lark Technologies) is UK based provider of DNA sequencing to pharmaceutical, biotech and academic institutes with a long history of working with the MRC.

Paul Tomlin, Director of European Operations, said, "We are very pleased to continue our relationship with the MRC and are confident of meeting the needs of MRC scientists across all 35 UK sites."

"Cogenics has over 17 years experience with DNA sequencing and other molecular biology services and as such is uniquely positioned to provide the best customer experience possible and to serve the needs of the MRC."

Cogenics provides comprehensive pharmacogenomics and molecular services to the scientific community with six sites across North America and Europe employing over 200 experienced scientists and other professionals.